Accession Number: | 0001209191-21-067067 |
Date: | 2021-11-24 |
Issuer: | MIRUM PHARMACEUTICALS, INC. (MIRM) |
Original Submission Date: |
PEETZ CHRISTOPHER
C/O MIRUM PHARMACEUTICALS, INC.
950 TOWER LANE, SUITE 1050
FOSTER CITY, CA 94404
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-11-24 | P | 7,000 | a | $14.40 | 28,027 | direct | ||
COMMON STOCK | 2021-11-24 | 0 | $0.00 | 201,570 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reporting person's purchase of mirm common stock reported herein was matchable under section 16(b) of the securities exchange act of 1934 with the reporting person's sale of 3,672 shares of mirm common stock on october 1, 2021 at a price of $19.256. the transaction resulted in short-swing profits of $17,831.23 which the reporting person has disgorged to mirm in accordance with section 16(b) of the securities exchange act of 1934. |